Atrium Therapeutics, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
12.77
-0.22 (-1.69%)
At close: Apr 30, 2026, 4:00 PM EDT
12.96
+0.19 (1.49%)
After-hours: Apr 30, 2026, 4:16 PM EDT
Atrium Therapeutics Analyst Ratings
Total Analysts
18
Consensus Rating
Buy
Price Target
$66.12
Upside
+417.78%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Initiates $25 | Buy | Initiates | $25 | +95.77% | Mar 11, 2026 |
| Chardan Capital | Chardan Capital | Hold Maintains $72 | Hold | Maintains | $72 | +463.82% | Nov 11, 2025 |
| TD Cowen | TD Cowen | Strong Buy → Hold Downgrades $78 → $74 | Strong Buy → Hold | Downgrades | $78 → $74 | +479.48% | Oct 29, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy → Hold Downgrades $75 → $72 | Strong Buy → Hold | Downgrades | $75 → $72 | +463.82% | Oct 28, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $61 → $72 | Buy → Hold | Downgrades | $61 → $72 | +463.82% | Oct 28, 2025 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $75 → $72 | Strong Buy → Hold | Downgrades | $75 → $72 | +463.82% | Oct 27, 2025 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $65 → $72 | Buy → Hold | Downgrades | $65 → $72 | +463.82% | Oct 27, 2025 |
| Raymond James | Raymond James | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 27, 2025 |
| Bernstein | Bernstein | Buy → Hold Downgrades $52 → $72 | Buy → Hold | Downgrades | $52 → $72 | +463.82% | Oct 27, 2025 |
| Needham | Needham | Strong Buy → Hold Downgrades $65 | Strong Buy → Hold | Downgrades | $65 | +409.01% | Oct 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $87 → $72 | Strong Buy → Hold | Downgrades | $87 → $72 | +463.82% | Oct 27, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $70 → $65 | Buy | Maintains | $70 → $65 | +409.01% | Sep 22, 2025 |
| Roth Capital | Roth Capital | Strong Buy Initiates $62 | Strong Buy | Initiates | $62 | +385.51% | Sep 17, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $56 → $65 | Strong Buy | Maintains | $56 → $65 | +409.01% | Sep 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $68 → $87 | Strong Buy | Maintains | $68 → $87 | +581.28% | Sep 12, 2025 |
| Needham | Needham | Strong Buy Maintains $60 → $65 | Strong Buy | Maintains | $60 → $65 | +409.01% | Sep 10, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.